Company intelligence / Profile preview

Age-Regression.Com

Ownership: Private
Employees: ~5
Development stage: Preclinical

Overview

The company focuses on biological age regression research and interventions. They highlight research on young plasma therapy which has shown potential to rejuvenate aged tissues, reduce biological aging markers, and enhance cognitive function[5].

Therapeutic areas: OtherNeurology
Modalities: Young plasmaISRIB
Industry: Biomedical IT and Biomedical Data Platforms

Drug pipeline

2 assets

ISRIB

Pre-clinical

Indications: Age-related cognitive decline, Alzheimer's disease, Amyotrophic lateral sclerosis, Down syndrome, Hearing loss, Traumatic brain injury

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on Age-Regression.Com.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Age-Regression.Com.

Explore the full profile